首頁 > 市場調查報告書 > 醫療設備

體外診斷

南美洲和中美洲免疫診斷市場預測至 2030 年 - 區域分析 - 按產品（酶聯免疫吸附測定、化學發光免疫測定、放射免疫測定等）、臨床適應症和最終用戶

市場調查報告書

商品編碼

1402450

南美洲和中美洲免疫診斷市場預測至 2030 年 - 區域分析 - 按產品（酶聯免疫吸附測定、化學發光免疫測定、放射免疫測定等）、臨床適應症和最終用戶

South & Central America Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), Clinical Indication, and End User

出版日期: 2023年10月27日 | 出版商:

The Insight Partners | 英文 199 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

南美洲和中美洲免疫診斷市場預計將從2023年的9.5572億美元成長到2030年的16.4852億美元。預計2023年至2030年CAGR為8.1%。

傳染病發生率的增加推動了南美洲和中美洲工業機器人市場

由病毒、真菌、細菌、寄生蟲或其有毒產物等感染原引起的幾種不斷成長的傳染病的診斷和治療，免疫診斷測試的處方數量激增，例如補體結合、沉澱測試、凝集測試、線印跡分析、蛋白質印跡分析、酵素免疫分析(EIA) 和免疫螢光測試。

人類免疫缺乏病毒（HIV）仍然是世界範圍內的一個主要公共衛生問題。

此外，結核病 (TB)、COVID-19 和其他院內感染 (HAIs) 需要進行免疫診斷測試。

結核病已成為第 13 大死因，也是僅次於 COVID-19 的第二大傳染病殺手。 2020 年，全球有 150 萬人死於結核病，估計有 1,000 萬人受到影響，其中包括 560 萬名男性、330 萬名女性和 110 萬名兒童。

據 Worldometer 稱，全球報告了數百萬人因 COVID-19 大流行而死亡。它給醫療保健系統帶來了壓力，並增加了對免疫診斷測試的需求。

診斷在確定合適的醫療方法方面發揮著至關重要的作用。免疫診斷有助於診斷嚴重影響免疫系統的疾病。因此，傳染病盛行率的上升導致對免疫診斷產品的需求激增。

南美洲和中美洲免疫診斷市場概述

根據《2019年世界人口老化》報告，2019年巴西65歲以上人口數為1952.6萬人，預計到2050年將達到5202.6萬人。老年人口的增加預計將提高該國肝病、糖尿病等疾病的患病率。結腸癌和胰腺癌，因為老年人更容易患這些癌症以及其他慢性疾病，這將隨後增加對診斷的需求。細菌和病毒大流行的大規模爆發、對即時診斷的需求不斷增加以及技術的快速發展正在進一步推動分子診斷的發展。例如，2020 年 11 月，專注於傳染病的領先即時診斷公司 Chembio Diagnostics, Inc. 透露，其子公司 Chembio Diagnostics Brazil Ltda 獲得了國家衛生局 (ANVISA) 批准用於 DPP SARS-巴西的CoV-2 抗原測試系統。在巴西，非傳染性疾病也構成了嚴重的健康問題，佔死因的 72%，特別是心血管疾病（31.3%）、癌症（16.3%）、糖尿病（5.2%）和慢性呼吸道疾病（5.8%））。因此，癌症、糖尿病和其他慢性疾病病例的不斷增加，對免疫診斷的需求激增。

南美洲及中美洲免疫診斷市場收入及 2030 年預測（百萬美元）

南美洲和中美洲免疫診斷市場細分

南美洲和中美洲免疫診斷市場分為產品、臨床適應症、最終用戶和國家。

根據產品，南美洲和中美洲免疫診斷市場分為酵素連結免疫吸附測定（ELISA）、化學發光免疫測定（CLIA）、放射免疫測定（RIA）等。 2023 年，酵素連結免疫吸附測定 (ELISA) 領域在南美洲和中美洲免疫診斷市場中佔據最大佔有率。化學發光免疫分析 (CLIA) 領域進一步細分為維生素 D 分析市場、HIV 檢測市場、HIV a/ab 組合分析市場和其他測試。

根據臨床適應症，南美洲和中美洲免疫診斷市場分為傳染病、肝炎+HIV、內分泌、胃腸道、代謝等。 2023年，傳染病領域在南美洲和中美洲免疫診斷市場中佔據最大佔有率。傳染病細分為 COVID-19、結核病、萊姆病、感染管理、寨卡病毒、密螺旋體、火炬、麻疹和腮腺炎、水痘帶狀皰疹病毒和 EB 病毒。內分泌科進一步細分為高血壓、生長、糖尿病、甲狀腺和生殖內分泌。

根據最終用戶，南美洲和中美洲免疫診斷市場分為醫院、診所、診斷實驗室、學術和研究機構等。 2023年，醫院細分市場在南美洲和中美洲免疫診斷市場中佔據最大佔有率。

根據國家/地區，南美洲和中美洲免疫診斷市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2023年，南美洲和中美洲其他地區在南美洲和中美洲免疫診斷市場中佔據最大佔有率。

雅培實驗室；生物梅里埃公司；丹納赫公司； DiaSorin SpA； F.霍夫曼-拉羅氏有限公司；珀金埃爾默公司；深圳邁瑞生物醫療電子有限公司；西門子醫療保健有限公司；斯瓦爾生命科學公司；和 Thermo Fisher Scientific Inc 是南美洲和中美洲免疫診斷市場上的一些領先公司。

研究範圍
Insight Partners 研究報告指南
市場區隔
- 南美洲和中美洲免疫診斷市場 - 按產品
- 南美洲和中美洲免疫診斷市場 - 按臨床適應症
- 南美洲和中美洲免疫診斷市場 - 按最終用戶分類
- 南美洲和中美洲免疫診斷市場 - 按國家/地區

第 2 章：南美洲和中美洲免疫診斷市場 - 要點

第 3 章：研究方法

覆蓋範圍
二次研究
初步研究

第 4 章：南美洲和中美洲免疫診斷市場 - 市場模式

概述
南美洲和中美洲 PEST 分析
專家意見

第 5 章：南美洲和中美洲免疫診斷市場 - 主要市場動態

市場促進因素
- 傳染病病率增加
- 床邊免疫診斷的使用不斷增加
市場限制
- 報銷不足的情況
市場機會
- 關鍵參與者日益關注研發投資和擴張
未來的趨勢
- 免疫診斷的技術進步
影響分析

第 6 章：免疫診斷市場 - 南美洲和中美洲分析

南美洲與中美洲免疫診斷市場收入預測與分析

第 7 章：南美洲和中美洲免疫診斷市場分析 - 按產品

概述
南美洲和中美洲免疫診斷市場（按產品），2022 年和 2030 年 (%)
酵素連結免疫吸附測定法 (ELISA)
化學發光免疫分析 (CLIA)
放射免疫分析 (RIA)
其他

第 8 章：南美洲和中美洲免疫診斷市場分析 - 臨床適應症

概述
南美洲和中美洲免疫診斷市場佔有率（按臨床適應症） - 2022 年和 2030 年（%）
傳染性疾病：
- 概述
  - 新冠肺炎
  - 結核
  - 萊姆病
  - 感染管理
  - 寨卡病毒
  - 密螺旋體屬
  - 火炬
  - 麻疹和腮腺炎
  - VZV
  - EB病毒
肝炎+愛滋病毒：
- 概述
胃腸道
- 概述
代謝紊亂
- 概述
內分泌科
- 概述
- 高血壓
  - 概述
- 生長
  - 概述
- 糖尿病
  - 概述
- 甲狀腺
  - 概述
- 生殖內分泌學
  - 概述
其他
- 概述

第 9 章：南美洲和中美洲免疫診斷市場分析 - 最終用戶

概述
南美洲和中美洲最終用戶免疫診斷市場佔有率 - 2022 年和 2030 年 (%)
醫院
- 概述
診所
- 概述
診斷實驗室
- 概述
學術及研究機構
- 概述
其他
- 概述

第 10 章：南美洲和中美洲免疫診斷市場 - 收入和 2030 年預測 - 國家分析

概述

第 11 章：南美洲和中美洲免疫診斷市場 - 產業格局

概述
南美洲和中美洲免疫診斷市場的成長策略
無機成長策略
- 概述
有機成長策略
- 概述

第 12 章：公司簡介

Abbott Laboratories
F. Hoffmann-La Roche Ltd
DiaSorin SpA
Danaher Corp
Thermo Fisher Scientific Inc
PerkinElmer Inc
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
bioMerieux SA
Svar Life Science AB
Siemens Healthcare GmbH

第 13 章：附錄

關於 Insight Partners
專業術語

簡介目錄圖表

Product Code: BMIRE00027836

The South & Central America immunodiagnostics market is expected to grow from US$ 955.72 million in 2023 to US$ 1,648.52 million by 2030. It is estimated to grow at a CAGR of 8.1% from 2023 to 2030.

Increasing Prevalence of Infectious Diseases Drive South & Central America Industrial Robotics Market

The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are surging number of prescriptions for immunodiagnostics tests, e.g., complement fixation, precipitation tests, agglutination tests, line blot assays, Western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests.

Human immunodeficiency virus (HIV) continues to be a major public health issue worldwide.

Further, tuberculosis (TB), COVID-19, and other hospital-acquired infections (HAIs) require immunodiagnostics tests.

TB has been the 13th leading cause of death and the second-leading infectious killer after COVID-19. In 2020, 1.5 million people died from TB and affected an estimated 10 million people, comprising 5.6 million males, 3.3 million females, and 1.1 million children globally.

According to Worldometer, millions of deaths were reported worldwide due to the COVID-19 pandemic. It strained healthcare systems and increased the need for immunodiagnostics tests.

Diagnostics play a vital role in determining suitable medical treatments. Immunodiagnostics help diagnose diseases that severely impact the immune system. Hence, the rising prevalence of infectious diseases lead to the surging demand for immunodiagnostics products.

South & Central America Immunodiagnostics Market Overview

According to World Population Ageing 2019 report, the number of people aged above 65 years was 19.526 million in Brazil in 2019 and is expected to reach 52.026 million by 2050. This increase in the geriatric population is expected to raise the country's prevalence rate of liver, colon, and pancreatic cancer since older people are more prone to these cancers, as well as other chronic diseases, which would subsequently boost the demand for diagnostics. Large outbreaks of bacterial and viral pandemics, increasing demand for point-of-care diagnostics, and rapidly evolving technology are further propelling the growth of molecular diagnostics. For instance, in November 2020, Chembio Diagnostics, Inc., a leading point-of-care diagnostic company focused on infectious diseases, revealed that its subsidiary Chembio Diagnostics Brazil Ltda received Agencia Nacional de Vigilancia Sanitaria (ANVISA) approval for the DPP SARS-CoV-2 Antigen test system in Brazil. In Brazil, NCDs also constitute a health problem of a large magnitude and account for 72% of causes of death, especially cardiovascular diseases (31.3%), cancer (16.3%), diabetes (5.2%), and chronic respiratory disease (5.8%). Thus, the rising cases of cancer, diabetes, and other chronic diseases is surging the demand for immunodiagnostics.

South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Immunodiagnostics Market Segmentation

The South & Central America immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the South & Central America immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered the largest share in the South & Central America immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.

Based on clinical indication, the South & Central America immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered the largest share in the South & Central America immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.

Based on end user, the South & Central America immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered the largest share in the South & Central America immunodiagnostics market.

Based on country, the South & Central America immunodiagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2023, the Rest of South & Central America segment registered the largest share in the South & Central America immunodiagnostics market.

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America immunodiagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America immunodiagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Immunodiagnostics Market - by Product
- 1.3.2 South & Central America Immunodiagnostics Market - by Clinical Indication
- 1.3.3 South & Central America Immunodiagnostics Market - by End User
- 1.3.4 South & Central America Immunodiagnostics Market - by Country

2. South & Central America Immunodiagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Immunodiagnostics Market - Market Landscape

4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert's Opinion

5. South & Central America Immunodiagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Infectious Diseases
- 5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
- 5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
- 5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
- 5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis

6. Immunodiagnostics Market - South & Central America Analysis

6.1 South & Central America Immunodiagnostics Market Revenue Forecast and Analysis

7. South & Central America Immunodiagnostics Market Analysis - by Product

7.1 Overview
7.2 South & Central America Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
- 7.3.1 Overview
- 7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
- 7.4.1 Overview
- 7.4.2 Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Vitamin D Assay
  - 7.4.3.1 Overview
  - 7.4.3.2 Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 HIV Detection
  - 7.4.4.1 Overview
  - 7.4.4.2 HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 HIV Ag/Ab Combo assay
  - 7.4.5.1 Overview
  - 7.4.5.2 HIV Ag/Ab Combo Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.6 Other Tests
  - 7.4.6.1 Overview
  - 7.4.6.2 Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
- 7.5.1 Overview
- 7.5.2 Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Immunodiagnostics Market Analysis - Clinical Indication

8.1 Overview
8.2 South & Central America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 COVID-19
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 COVID-19: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Tuberculosis
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Lyme
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Infection Management
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Zika
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.6 Treponema
    - 8.3.2.6.1 Overview
    - 8.3.2.6.2 Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.7 TORCH
    - 8.3.2.7.1 Overview
    - 8.3.2.7.2 TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.8 Measles and Mumps
    - 8.3.2.8.1 Overview
    - 8.3.2.8.2 Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.9 VZV
    - 8.3.2.9.1 Overview
    - 8.3.2.9.2 VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.10 EBV
    - 8.3.2.10.1 Overview
    - 8.3.2.10.2 EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
- 8.4.1 Overview
- 8.4.2 Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
- 8.5.1 Overview
- 8.5.2 Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
- 8.6.1 Overview
- 8.6.2 Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
- 8.7.1 Overview
- 8.7.2 Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.3 Hypertension
  - 8.7.3.1 Overview
  - 8.7.3.2 Hypertension: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.4 Growth
  - 8.7.4.1 Overview
  - 8.7.4.2 Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.5 Diabetes
  - 8.7.5.1 Overview
  - 8.7.5.2 Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.6 Thyroid
  - 8.7.6.1 Overview
  - 8.7.6.2 Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.7 Reproductive Endocrinology
  - 8.7.7.1 Overview
  - 8.7.7.2 Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Immunodiagnostics Market Analysis - End User

9.1 Overview
9.2 South & Central America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 Clinics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
- 9.6.1 Overview
- 9.6.2 Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Overview

11. South & Central America Immunodiagnostics Market -Industry Landscape

11.1 Overview
11.2 Growth Strategies in the South & Central America immunodiagnostics market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DiaSorin SpA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Danaher Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 PerkinElmer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 bioMerieux SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Svar Life Science AB
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Brazil Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 2. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of South & Central America Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Recent Inorganic Growth Strategies in the South & Central America immunodiagnostics market
Table 20. Recent Organic Growth Strategies in the South & Central America immunodiagnostics market
Table 21. Glossary of Terms, South & Central America Immunodiagnostics Market

List Of Figures

Figure 1. South & Central America Immunodiagnostics Market Segmentation
Figure 2. South & Central America Immunodiagnostics Market, by Country
Figure 3. South & Central America Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in South & Central America Immunodiagnostics Market
Figure 5. Argentina Expected to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. South & Central America Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
Figure 10. South & Central America Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 20. Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 29. VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. South & Central America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 42. Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 43. Clinics: South & Central America Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 44. Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 45. Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 46. Others: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 47. South & Central America Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. South & Central America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 49. Brazil: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 50. Argentina: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. Rest of South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. Growth Strategies in the South & Central America immunodiagnostics market